Sharechat Logo

Ryman Healthcare debt facilities update

Tuesday 10th September 2024

Text too small?

Ryman Healthcare (Ryman) has agreed amendments to its debt covenants and extended one of its banking facilities.

 

Ryman’s interest coverage ratio (ICR) covenant levels, which apply to both bank facilities and its institutional term loan (ITL), have been amended for testing periods through to March 2026 (see table below). The ICR covenant level remains at 2.25x for testing periods beyond this. There has been no change to the ICR covenant calculation (being adjusted EBITDA to gross interest expense1), Ryman’s other financial covenants or Ryman’s loan margins.

 

Chief Financial Officer Rob Woodgate said, “As signaled in our Business Improvement Performance Update on 2 September 2024, given the continued uncertainty around residential property market conditions in the near term, we believe a prudent step is to attain additional covenant headroom for upcoming testing periods. Discussions with our lenders have been positive and they remain very supportive of Ryman.”

 

In addition, a $115 million bank facility, previously maturing on 30 September 2024,

has been extended to 1 April 2026.

 

Ryman’s debt facilities total NZ$3,018 million which comprises syndicated bank facilities of NZ$2,598 million2, a retail bond of NZ$150 million and an ITL of A$250 million. The average term to maturity across all facilities is 2.8 years at 10 September 2024.

 

ICR covenant table

12 months to 30 September 2024, Previous: 1.75x, Amended: 1.50x

12 months to 31 March 2025, Previous: 1.75x, Amended: 1.50x

12 months to 30 September 2025, Previous: 2.00x, Amended: 1.75x

12 months to 31 March 2026, Previous: 2.25x, Amended: 2.00x

 

ENDS

 

About Ryman:

Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49 retirement villages in New Zealand and Australia. Ryman villages are home to 14,600 residents, and the company employs 7,700 staff.

 

Contacts:

For investor relations information contact Hayden Strickett, Head of Investor Relations, on 027 303 1132 (+64 27 303 1132) or email hayden.strickett@rymanhealthcare.com

 

For media information or images contact Camille Middleditch on 028 422 3472 or camille.middleditch@rymanexternal.com

 

1: See Appendix 11 in Ryman Healthcare’s 2024 result presentation for further detail (link).

2: Includes Australian dollar and multi-currency facilities, both presented in New Zealand dollars.

 

 



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

TRU - WHO Agency UNITAID Features TRU in Tech Landscape Report
PaySauce Quarterly Market Update - September 2024
October 2nd Morning Report
Rua Releases Annual Report for Year Ended 30 June 2024
SCL - Settlement of orchard sales
The Warehouse Group 2024 ASM and Director Nominations
AIR - Update on Chief Operational Integrity and Safety Officer
Comvita Limited - Annual Report 2024
September 27th Morning Report
Spark announces departure of Finance Director